Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population

Infection, Genetics and Evolution

Volumn 27, Issue , 2014, Pages 77-82

  Su, Zhenzhen ^a   Li, Yi ^a   Liao, Yun ^a   Cai, Bei ^a   Chen, Jie ^a   Zhang, Junlong ^a   Li, Lixin ^a   Ying, Binwu ^a   Tao, Chuanmin ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

HBV; Hepatocellular carcinoma; HRM; SNP; Sodium taurocholate cotransporting polypeptide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; SODIUM BILE ACID COTRANSPORTER; COTRANSPORTER; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NTCP GENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; ALLELE; CARCINOMA, HEPATOCELLULAR; CHINA; COMPLICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HEPATITIS B VIRUS; LIVER NEOPLASMS; MIDDLE AGED; ODDS RATIO; VIROLOGY; GENETIC DIFFERENCE; GENOTYPING TECHNIQUE; HAN CHINESE;

ADULT; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PATIENT OUTCOME ASSESSMENT; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SYMPORTERS;

EID: 84904758138     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.07.001     Document Type: Article

References (35)

1. An P., Winkler C., Guan L., O'Brien S.J., Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J. Infect. Dis. 2011, 203:943-947.
2. Ansel J., Bottin H., Rodriguez-Beltran C., Damon C., Nagarajan M., Fehrmann S., Francois J., Yvert G. Cell-to-cell stochastic variation in gene expression is a complex genetic trait. PLoS Genet. 2008, 4:e1000049.
3. Arzumanyan A., Reis H.M., Feitelson M.A. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 2013, 13:123-135.
4. Austin P.C., Laupacis A. A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: a review. Int. J. Biostat. 2011, 7:6.
5. Chen J., Wang L., Li Y., Cai B., Fu Y., Liao Y., Zhang J. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS ONE 2012, 7:e50787.
6. Chen P.J., Wu T.C. One step closer to an experimental infection system for hepatitis B virus? - the identification of sodium taurocholate cotransporting peptide as a viral receptor. Cell Biosci. 2013, 3:2.
7. Chen Z.J., Ye J. Getting to grips with hepatitis. eLife 2012, 1:e00301.
8. Chu C.M., Liaw Y.F. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatol. (Baltimore, Md.) 2007, 45:1187-1192.
9. Conde S.R., Feitosa R.N., Freitas F.B., Hermes R.B., Demachki S., Araujo M.T., Soares M.C., Ishak R., Vallinoto A.C. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B. Cytokine 2013, 61:940-944.
10. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142(1264-1273):e1261.
11. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
12. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 2008, 48:335-352.
13. Glebe D., Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol.: WJG 2007, 13:22-38.
14. Gripon P., Cannie I., Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 2005, 79:1613-1622.
15. Guo X., Zhang Y., Li J., Ma J., Wei Z., Tan W., O'Brien S.J. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the han chinese population. Hepatol. (Baltimore, Md.) 2011, 53:422-428.
16. Hill W.G., Mulder H.A. Genetic analysis of environmental variation. Genet. Res. 2010, 92:381-395.
17. Ho R.H., Leake B.F., Roberts R.L., Lee W., Kim R.B. Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J. Biol. Chem. 2004, 279:7213-7222.
18. Jee S.H., Ohrr H., Sull J.W., Samet J.M. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J. Natl. Cancer Inst. 2004, 96:1851-1856.
19. Liaw Y.F., Chu C.M. Hepatitis B virus infection. Lancet 2009, 373:582-592.
20. Liaw Y.F., Leung N., Kao J.H., Piratvisuth T., Gane E., Han K.H., Guan R., Lau G.K., Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hep. Intl. 2008, 2:263-283.
21. Meier A., Mehrle S., Weiss T.S., Mier W., Urban S. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatol. (Baltimore, Md.) 2013, 58:31-42.
22. Michielsen P., Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol. Belg. 2011, 74:4-8.
23. Ni Y., Lempp F.A., Mehrle S., Nkongolo S., Kaufman C., Falth M., Stindt J., Koniger C., Nassal M., Kubitz R., Sultmann H., Urban S. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2013.
24. Nishida N., Sawai H., Matsuura K., Sugiyama M., Ahn S.H., Park J.Y., Hige S., Kang J.H., Suzuki K., Kurosaki M., Asahina Y., Mochida S., Watanabe M., Tanaka E., Honda M., Kaneko S., Orito E., Itoh Y., Mita E., Tamori A., Murawaki Y., Hiasa Y., Sakaida I., Korenaga M., Hino K., Ide T., Kawashima M., Mawatari Y., Sageshima M., Ogasawara Y., Koike A., Izumi N., Han K.H., Tanaka Y., Tokunaga K., Mizokami M. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE 2012, 7:e39175.
25. Pan N., Jiang W., Sun H., Miao F., Qiu J., Jin H., Xu J., Shi Q., Xie W., Zhang J. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study. PLoS ONE 2011, 6:e25682.
26. Patel M., Shariff M.I., Ladep N.G., Thillainayagam A.V., Thomas H.C., Khan S.A., Taylor-Robinson S.D. Hepatocellular carcinoma: diagnostics and screening. J. Eval. Clin. Pract. 2012, 18:335-342.
27. Tian Y., Kuo C.F., Chen W.L., Ou J.H. Enhancement of hepatitis B virus replication by androgen and its receptor in mice. J. Virol. 2012, 86:1904-1910.
28. Visel A., Rubin E.M., Pennacchio L.A. Genomic views of distant-acting enhancers. Nature 2009, 461:199-205.
29. Wang S.H., Yeh S.H., Lin W.H., Yeh K.H., Yuan Q., Xia N.S., Chen D.S., Chen P.J. Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha. Gastroenterology 2012, 142(989-998):e984.
30. Wu M.H., Ma W.L., Hsu C.L., Chen Y.L., Ou J.H., Ryan C.K., Hung Y.C., Yeh S., Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci. Transl. Med. 2010, 2:32ra35.
31. Yan H., Peng B., He W., Zhong G., Qi Y., Ren B., Gao Z., Jing Z., Song M., Xu G., Sui J., Li W. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J. Virol. 2013, 87:7977-7991.
32. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., Wang H., Fu L., Song M., Chen P., Gao W., Ren B., Sun Y., Cai T., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012, 1:e00049.
33. Yin J., Xie J., Zhang H., Shen Q., Han L., Lu W., Han Y., Li C., Ni W., Wang H., Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J. Gastroenterol. 2010, 45:1063-1071.
34. Yu M.W., Yang Y.C., Yang S.Y., Cheng S.W., Liaw Y.F., Lin S.M., Chen C.J. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J. Natl. Cancer Inst. 2001, 93:1644-1651.
35. Zhong G., Yan H., Wang H., He W., Jing Z., Qi Y., Fu L., Gao Z., Huang Y., Xu G., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of tupaia hepatocytes. J. Virol. 2013, 87:7176-7184.